{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-014716","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2022-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.614231+00:00","generated_at":"2026-06-25T08:10:41.984876+00:00","sec_items":["5.08"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Bone Biologics sets 2022 Annual Meeting for August 23; stockholder proposal deadline June 23","bullets":["2022 Annual Meeting scheduled for August 23, 2022; record date June 24, 2022.","No 2021 Annual Meeting held; revised deadlines apply for stockholder proposals.","Deadline for Rule 14a-8 proposals and director nominations is June 23, 2022.","Proposals must be sent to Corporate Secretary at Burlington, MA address."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-014716","json":"https://secwatch.observer/filing/0001493152-22-014716.json","markdown":"https://secwatch.observer/filing/0001493152-22-014716.md","text":"https://secwatch.observer/filing/0001493152-22-014716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222014716/0001493152-22-014716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222014716/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T08:10:41.984876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}